EUVIMEDEUVIMED entdecken
Crossref

Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand Factor Secretion and Thrombosis

Xin-Yi Yu, Xin-Yu Jia, Ting-Yu Wang, Yan-Hong Zhang, Hao Song, Kan Li, Zhuo-Zheng Chen, Yi Zhu, Liu Yao

Thrombosis and Haemostasis · 01.09.2025 · 125 (09) · 847-858

DOI: 10.1055/a-2471-8767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.09.2025. Verfasst von Xin-Yi Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin…. Hauptthemen laut MEDLINE: von Willebrand Factor, Inositol 1,4,5-Trisphosphate Receptors, Thrombosis, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with coronavirus disease 2019 (COVID-19) are at high risk of developing a hypercoagulable state and thrombosis. The von Willebrand factor (vWF) produced by endothelial cells (ECs) is a critical thrombosis regulator. We previously found that cytoskeleton-associated protein 4 (CKAP4) is a novel receptor for the spike protein of severe acute respiratory syndrome coronavirus-2 and is involved in COVID-19-associated coagulopathy. However, the underlying mechanism involved remains unclear. This study aimed to explore the signaling pathways involved in spike protein-CKAP4-induced vWF secretion and thrombosis. Treatment of ECs with the spike protein significantly induced vWF secretion, coagulation factor VIII (FVIII)–vWF binding, and platelet adhesion to ECs, which were blocked by the selective intracellular calcium chelator, BAPTA-AM. Furthermore, using several calcium channel-blocking drugs and small-molecule inhibitors, we found that calcium released from the endoplasmic reticulum (ER) is involved in this process. IP3 (inositol 1,4,5-trisphosphate) receptors (IP3Rs) inhibition ameliorated spike protein-induced vWF secretion, FVIII–vWF binding affinity, and platelet adhesion to ECs. Specifically, the knockdown of IP3R1, a crucial type of IP3Rs, reversed spike protein-induced endothelial vWF secretion, and the procoagulant state. Moreover, KT-362, an investigational and clinically relevant antihypertensive drug targeting IP3Rs-mediated calcium release, repressed spike protein-induced endothelial vWF secretion. Conversely, the IP3Rs agonist promoted endothelial vWF secretion, which was not affected by CKAP4 knockdown. In vivo treatment of endothelial-specific human CKAP4 overexpression mice with KT-362 retarded spike protein-induced vWF secretion and thrombosis. Thus, IP3Rs mediated calcium release from the ER and contributed to spike protein-induced vWF secretion and thrombosis, making them potential therapeutic targets for COVID-19-associated coagulopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand FactorInositol 1,4,5-Trisphosphate ReceptorsThrombosisCOVID-19SARS-CoV-2Endothelial CellsHumansAnimalsSpike Glycoprotein, CoronavirusMiceCalciumPlatelet AdhesivenessCalcium Signaling

Substanzen

von Willebrand FactorInositol 1,4,5-Trisphosphate ReceptorsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Calcium

Autor:innen und Institutionen

  • The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Yu, X. Y., Jia, X. Y., Wang, T. Y., Zhang, Y. H., Song, H., Li, K., Chen, Z. Z., Zhu, Y., & Yao, L. (2025). Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand Factor Secretion and Thrombosis. Thrombosis and Haemostasis, 125(09), 847-858. https://doi.org/10.1055/a-2471-8767

Vancouver

Yu XY, Jia XY, Wang TY, Zhang YH, Song H, Li K, et al. Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand Factor Secretion and Thrombosis. Thrombosis and Haemostasis. 2025;125(09):847-858. doi:10.1055/a-2471-8767

BibTeX
@article{Yu2025,
  author = {Yu, Xin-Yi and Jia, Xin-Yu and Wang, Ting-Yu and Zhang, Yan-Hong and Song, Hao and Li, Kan and Chen, Zhuo-Zheng and Zhu, Yi and Yao, Liu},
  title = {Inhibition of IP3 (Inositol 1,4,5-Trisphosphate) Receptors Retards SARS-CoV-2-Induced Endothelial von Willebrand Factor Secretion and Thrombosis},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {09},
  pages = {847--858},
  doi = {10.1055/a-2471-8767}
}
Kostenlos starten →